MIAMI - eTradeWire -- RevGenetics is disrupting the metabolic support market today with the commercial launch of DiBerberine 300x, an advanced enteric-coated dihydroberberine (DHB) supplement. By directly addressing the industry-wide "berberine absorption gap," RevGenetics exposes a flaw found in nearly every major competing brand: the failure to protect the active compound from stomach acid degradation and P-glycoprotein (P-gp) efflux pumps.

"The question we kept asking was: why is the supplement industry selling a mechanism - AMPK activation - with a delivery system that undermines the mechanism?" said RevGenetics founder Anthony Loera. "Most every major brand in the berberine category is selling a standard vegetarian capsule with berberine. Nobody in the supplement industry was solving them in a single product."

More on eTradeWire News

• Golden State Warriors Game-Used Basketball Court Collection Launch at Artsman
• UVify to Showcase Advanced Unmanned Systems and Autonomous Capabilities at SOF Week 2026 in Tampa
• Where Southern Heritage Meets Cinematic Excellence: AlabamaPictureCars.com Arrives
• Screen Gems: Movies & TV Puzzle Book Launches to Celebrate Film, Streaming, and Entertainment TV
• Police Officers' Defense Coalition Responds to House Vote on H. Con. Res. 96

Unlike standard formulas, The DiBerberine 300x Triple-Action Protocol sets a new standard by combining:

• Enteric Capsule Technology: Borrowing from pharmaceutical methods, this acid-resistant capsule bypasses the stomach without dissolving, preventing DHB from reverting to standard berberine HCl and ensuring release in the small intestine.
• DiBerberine™ Proprietary Blend (500mg per capsule): This leverages the profound pharmacokinetic advantage of DHB. A 2022 study showed a 100mg dose yielded ~6.7x greater plasma exposure than 500mg of standard berberine HCl.
• RGBooster1™: A patent-pending (U.S. App. No. 63/837,080) flavonoid complex. Internal assays demonstrate our Sophora japonica extract is up to 300x more potent than piperine at modulating the P-gp active transport mechanism that expels compounds from intestinal cells.

"Enteric coating isn't new technology," Loera stated. "Applying that technology to DHB was the obvious move. It just hadn't been done in a commercially available formula."

More on eTradeWire News

• Justplug Addresses Liberty Utilities Crisis With Grid-Independent Solar for Rural California
• Save Money Car Insurance Expands in Tulsa with New Location and App Features
• Sold-Out 16th Annual Las Vegas Travel Agent Forum Highlights the Power of Connection
• Avery Headley Leads Major Stabilization and Modernization Initiative Across Bronx Affordable Housing Portfolio
• JoinRCMP.ca Releases New RCMP Salary Guide Covering Pay, Allowances, and Career Earnings

Manufactured in the USA in a cGMP-certified, third-party tested facility, DiBerberine 300x is now available at revgenetics.com. A 30-day supply (30 enteric capsules) is priced at $44.95.

Health and wellness influencers, practitioners, and marketers interested in partnering with RevGenetics for this launch can access the affiliate program at getlink.revgenetics.com.